Search for: "BRISTOL-MYERS SQUIBB" Results 301 - 320 of 863
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Sep 2011, 7:44 pm
A Reading, Massachusetts is the latest plaintiff of a Boston personal injury lawsuit seeking damages from drug manufacturers, including ex-DES drur makers Bristol-Myers Squibb and Eli Lilly, for her breast cancer. [read post]
3 Sep 2015, 7:34 am by Law Offices of Jeffrey S. Glassman
Eliquis, manufactured by Bristol-Myers Squibb (BMS) and Pfizer, is now claiming its new oral anticoagulant (NOAC) is safer than other NOACs (Xarelto, Pradaxa, and Savaysa), according to a recent news article from Medpage Today. [read post]
1 Mar 2013, 9:53 pm by Aparajita Lath
As reported, Bristol-Myers Squibb, Roche and Boehringer-Ingelheim have plans to join the pool. [read post]
22 Aug 2016, 12:53 pm by Tom Lamb
To overcome that headwind and broaden the use of their drugs, Johnson & Johnson, Bristol-Myers Squibb, and Pfizer provided funding to Portola Pharmaceuticals so it could develop AndexXa. [read post]
Supreme Court established limitations on personal jurisdiction over non-resident corporate defendants in state court “mass” actions in Bristol-Myers Squibb Co. v. [read post]
20 Dec 2006, 2:05 am
Christie, and Bristol-Myers Squibb. [read post]
14 Oct 2011, 6:43 am by Bexis
Bristol-Myers Squibb Co., 2011 WL 4708850 (D. [read post]
10 Jun 2015, 6:28 pm
Our client started working for Bristol-Myers Squibb in 1989 – staying with the company until she became disabled in November 2010. [read post]
14 Jun 2013, 6:23 pm
The Food and Drug Administration said it is considering setting up a study, either through the agency or the companies, that looks deeper into whether medicines for Type 2 diabetes, including Merck’s Januvia and Bristol Myers-Squibb Co. [read post]
23 Feb 2017, 7:21 am by Altman & Altman
As of December 2016, approximately 34 Eliquis lawsuits were pending against the drug’s manufacturers, Bristol-Myers Squibb and Pfizer, Inc. [read post]
26 Jun 2017, 8:26 am by Hall Marston
Pardon the Jimi Hendrix allusion, but it seemed appropriate given yesterday’s Supreme Court decision in Bristol-Myers Squibb Co. v. [read post]
26 Jun 2017, 8:26 am by Hall Marston
Pardon the Jimi Hendrix allusion, but it seemed appropriate given yesterday’s Supreme Court decision in Bristol-Myers Squibb Co. v. [read post]
19 Mar 2012, 4:16 am
Judge Birss QC assures us that his decision in Merck Sharp Dohme Corp & Anor v Teva Pharma BV & Anor [2012] EWHC 627 (Pat), relating to an application by Bristol-Myers Squibb for an interim injunction pending trial, raises no issue of principle, but he does provide an enlightening discussion of how to address some issues of fact that are common in an application for a quia timet injunction, including a review of the European case law. [read post]
2 Apr 2009, 1:01 pm
In our first post we particularly analyzed that both Bristol-Myer Squibb (BMS) and the Delhi High Court acted within the periphery of the law and the Delhi HC order nowhere created any sort of "patent-drug regulatory" linkage, an argument unnecessarily sensationalized and propagandized by newspaper media. [read post]